DuPont de Nemours, Inc. 2025 Q3 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2025. DuPont is undergoing significant structural changes, including the completed separation of its Electronics business into Qnity Electronics, Inc. (effective November 1, 2025) and a definitive agreement to sell its Aramids business (Kevlar and Nomex) to TJC LP for approximately $1.8 billion. The Aramids business is reported as discontinued operations beginning in Q3 2025. The company currently reports two segments: ElectronicsCo and IndustrialsCo, though a new segment realignment (Healthcare & Water Technologies and Diversified Industrials) is effective Q4 2025.
Key Financial Metrics
| Metric (in millions) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Net Sales | $3,072 | $2,862 | $8,720 | $8,263 |
| Income from Continuing Ops (Pre-tax) | $327 | $552 | $938 | $1,041 |
| Net Income (Loss) from Continuing Ops | $308 | $453 | $747 | $753 |
| Loss from Discontinued Ops (Net of Tax) | $(415) | $12 | $(1,365) | $93 |
| Net (Loss) Income | $(107) | $465 | $(618) | $846 |
| Diluted EPS (Continuing Ops) | $0.70 | $1.06 | $1.70 | $1.74 |
| Diluted EPS (Total) | $(0.29) | $1.08 | $(1.56) | $1.96 |
| Operating Cash Flow (Continuing) | N/A | N/A | $1,260 | $1,517 |
| Total Debt | $8,899 | N/A | N/A | N/A |
| Cash & Equivalents | $1,955 | N/A | N/A | N/A |
Note: Q3 2025 Net Loss is driven primarily by a $437 million loss on classification of Aramids assets to held-for-sale and a $768 million goodwill impairment charge within discontinued operations.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 7% in Q3 2025 and 6% for the nine months ended Sept 30, 2025, driven by volume growth (7% in Q3) in both ElectronicsCo (up 11%) and IndustrialsCo (up 5%).
- Discontinued Operations Impact: The Aramids divestiture resulted in a significant non-cash impairment charge ($768 million) and a loss on classification to held-for-sale ($437 million) in Q3 2025, turning a profitable prior-year period into a net loss.
- Separation Costs: Acquisition, integration, and separation costs rose to $139 million in Q3 2025 (vs. $43 million in Q3 2024) and $383 million for the nine months (vs. $51 million), primarily related to the Electronics Separation.
- Effective Tax Rate: The effective tax rate on continuing operations dropped to 5.8% in Q3 2025 (from 17.9% in Q3 2024) due to the release of a valuation allowance related to the Aramids divestiture.
- Debt Profile: Total debt increased to $8.9 billion, largely due to $1.75 billion in Qnity Notes issued in August 2025 to fund the spin-off distribution.
Guidance, Outlook, and Risks
- Capital Structure: DuPont expects to repay approximately $4.0 billion in senior notes following the Qnity spin-off and a tender offer for 2048 notes. A new $2 billion share repurchase authorization was approved in November 2025.
- Legal & Environmental (PFAS): The company reached a proposed Judicial Consent Order with the State of New Jersey to resolve PFAS and other legacy claims, recording a $177 million pre-tax charge (net present value of $311 million share). The company remains subject to ongoing litigation regarding PFAS, including the AFFF MDL.
- Trade Risks: Management highlights risks from new tariffs on imports from Canada, Mexico, and China, which could reduce competitiveness and sales.
- Segment Realignment: Effective Q4 2025, the company will report under two new segments: Healthcare & Water Technologies and Diversified Industrials.
Investor Verification Checklist
- Discontinued Operations Accounting: Verify the treatment of the $1.2 billion cash proceeds and $300 million note receivable from the Aramids sale and the impact of the $437 million valuation allowance on future earnings.
- Qnity Spin-Off Completion: Confirm the finalization of the Qnity distribution and the subsequent classification of ElectronicsCo results as discontinued operations in Q4 2025.
- PFAS Liability Exposure: Review the details of the New Jersey settlement and the Memorandum of Understanding (MOU) with Chemours and Corteva regarding the $4 billion cap on shared PFAS costs.
- Debt Refinancing: Monitor the execution of the tender offer for 2048 notes and the special mandatory redemption of new notes triggered by the spin-off.
- Segment Performance: Assess the standalone performance of the remaining IndustrialsCo businesses (Healthcare, Water, Diversified Industrials) once the Electronics segment is fully separated.